Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2015 1
2019 1
2020 1
2021 8
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
The management of myelofibrosis: A British Society for Haematology Guideline.
McLornan DP, Psaila B, Ewing J, Innes A, Arami S, Brady J, Butt NM, Cargo C, Cross NCP, Francis S, Frewin R, Garg M, Godfrey AL, Green A, Khan A, Knapper S, Lambert J, McGregor A, McMullin MF, Nangalia J, Neelakantan P, Woodley C, Mead A, Somervaille TCP, Harrison CN; BSH Committee. McLornan DP, et al. Among authors: woodley c. Br J Haematol. 2024 Jan;204(1):136-150. doi: 10.1111/bjh.19186. Epub 2023 Dec 1. Br J Haematol. 2024. PMID: 38037886 No abstract available.
Diagnosis and evaluation of prognosis of myelofibrosis: A British Society for Haematology Guideline.
McLornan DP, Godfrey AL, Green A, Frewin R, Arami S, Brady J, Butt NM, Cargo C, Ewing J, Francis S, Garg M, Harrison C, Innes A, Khan A, Knapper S, Lambert J, Mead A, McGregor A, Neelakantan P, Psaila B, Somervaille TCP, Woodley C, Nangalia J, Cross NCP, McMullin MF; BSH Committee. McLornan DP, et al. Among authors: woodley c. Br J Haematol. 2024 Jan;204(1):127-135. doi: 10.1111/bjh.19164. Epub 2023 Nov 6. Br J Haematol. 2024. PMID: 37932932 No abstract available.
How We Treat Myeloproliferative Neoplasms.
Harrison CN, McLornan DP, Francis YA, Woodley C, Provis L, Radia DH. Harrison CN, et al. Among authors: woodley c. Clin Lymphoma Myeloma Leuk. 2015 Jun;15 Suppl:S19-26. doi: 10.1016/j.clml.2015.02.032. Clin Lymphoma Myeloma Leuk. 2015. PMID: 26297273
Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys).
Okikiolu J, Woodley C, Cadman-Davies L, O'Sullivan J, Radia D, Garcia NC, Harrington P, Kordasti S, Asirvatham S, Sriskandarajah P, Saunders J, Saha C, Sanchez I, deLavallade H, McLornan DP, Harrison CN. Okikiolu J, et al. Among authors: woodley c. Leuk Res Rep. 2022 Dec 16;19:100360. doi: 10.1016/j.lrr.2022.100360. eCollection 2023. Leuk Res Rep. 2022. PMID: 36590864 Free PMC article.
Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T-cell phenotype.
Harrington P, Dillon R, Radia D, McLornan D, Woodley C, Asirvatham S, Raj K, Curto-Garcia N, Saunders J, Kordasti S, Harrison C, de Lavallade H. Harrington P, et al. Among authors: woodley c. Br J Haematol. 2022 Sep;198(6):1011-1015. doi: 10.1111/bjh.18302. Epub 2022 Jul 8. Br J Haematol. 2022. PMID: 35802024 Free PMC article.
Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib.
Harrington P, Doores KJ, Saunders J, de Lord M, Saha C, Lechmere T, Khan H, Lam HPJ, Reilly AO, Woodley C, Asirvatham S, Dillon R, Curto-Garcia N, Sullivan JO, Kordasti S, Raj K, Malim MH, Radia D, McLornan D, Harrison C, de Lavallade H. Harrington P, et al. Among authors: woodley c. Blood Cancer J. 2022 Apr 22;12(4):73. doi: 10.1038/s41408-022-00651-3. Blood Cancer J. 2022. PMID: 35459222 Free PMC article. No abstract available.
Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders.
Harrington P, Kurshan A, Delord M, Lechmere T, Sheikh A, Saunders J, Saha C, Dillon R, Woodley C, Asirvatham S, Curto-Garcia N, Sullivan JO, Kordasti S, Radia D, McLornan D, Malim MH, Harrison C, Doores KJ, de Lavallade H. Harrington P, et al. Among authors: woodley c. Blood Adv. 2023 May 23;7(10):1954-1957. doi: 10.1182/bloodadvances.2022008375. Blood Adv. 2023. PMID: 36083126 Free PMC article. No abstract available.
Patients with triple-negative, JAK2V617F- and CALR-mutated essential thrombocythemia share a unique gene expression signature.
Alimam S, Villiers W, Dillon R, Simpson M, Runglall M, Smith A, Chatzikyriakou P, Lavender P, Kanda A, Mills K, Bellosillo Paricio B, Kaufman-Cook J, Ord S, Kordasti S, Radia D, Woodley C, Francis Y, Mufti G, McLornan DP, Harrison CN. Alimam S, et al. Among authors: woodley c. Blood Adv. 2021 Feb 23;5(4):1059-1068. doi: 10.1182/bloodadvances.2020003172. Blood Adv. 2021. PMID: 33599741 Free PMC article.
Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.
Deschamps P, Moonim M, Radia D, Curto-Garcia N, Woodley C, Bassiony S, O'Sullivan J, Harrington P, Raj K, Francis Y, Kordasti S, Ali S, Harrison CN, McLornan DP. Deschamps P, et al. Among authors: woodley c. Br J Haematol. 2021 May;193(4):792-797. doi: 10.1111/bjh.17375. Epub 2021 Mar 9. Br J Haematol. 2021. PMID: 33751548
18 results